Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission ...
Bacteria in head and neck tumor stimulate immunotherapy resistance by attracting immune cells and creating a shield.
BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ ...
Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...
Science says marry the right person and you’ll be more successful, except for 1 (very personal) catch Archaeologists thought ...
An update from Alpha Tau Medical Ltd ( ($DRTS) ) is now available. On January 5, 2026, Alpha Tau Medical announced it has submitted the first ...
Industry star Marisa Abela shared an encouraging health update nearly six years after being diagnosed with thyroid cancer at ...
Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...
Vitamin B3, or niacin, is essential in small amounts for normal body function. The skin, nerves, and digestive system all ...
In vitro studies pinpoint signaling pathways that could be potential targets in oral squamous cell carcinoma treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback